Cite

HARVARD Citation

    Myers, A. et al. (2020). Phase II, 2‐stage, 2‐arm, PIK3CA mutation stratified trial of MK‐2206 in recurrent endometrial cancer. International journal of cancer. 147 (2), pp. 413-422. [Online]. 
  
Back to record